GSK builds new pediatric vaccine plant in Singapore

 The plant would represent a $300-million investment, and would start up in 2010. For more, read on. -AMS
June 8, 2006
 The plant would represent a $300-million investment, and would start up in 2010. For more, read on. -AMS

About the Author

pharmamanufacturing

pharmamanufacturing

Sign up for our eNewsletters
Get the latest news and updates

Related

Fujifilm Biotechnologies to leverage downstream purification system at UK site
AI usage in pharma supply chain is moving from pilots to practical deployment: report
Life Sciences Manufacturing Software Buyers Guide
Sponsored
AI Compliance in Life Sciences: 5 Essentials
Sponsored